Funds with similar focus
|Bar 9 Ventrues||-|
|Bayer Pharmaceuticals||Berlin, Berlin, Germany|
|blackprint Booster||Frankfurt, Germany, Hessen|
|Dongyang Hengdian Qiaobao Yingshi Wenhua Gongzuoshi||China, Dongyang, Zhejiang|
|Fenghui Consulting||China, Hangzhou, Zhejiang|
|Huaxi Holding||China, Jiangsu, Wuxi Shi|
|Intango Ventures||Israel, Tel Aviv, Tel Aviv District|
|Jackson Investment Group||Indiana, Indianapolis, United States|
|Joint Fortune Capital||China, Guangdong, Shenzhen|
|Karst Peak Capital||China, Hong Kong, Hong Kong Island|
|kocca||Seoul, Seoul-t'ukpyolsi, South Korea|
|Lindbergh Tech Fund||-|
|NABVENTURES Fund I||-|
|National Biofilms Innovation Centre||England, London, United Kingdom|
|Spring Ventures||Israel, Tel Aviv, Tel Aviv District|
|STARTPLATZ||Cologne, Germany, Nordrhein-Westfalen|
|Xingyu Co.,Ltd||Changzhou, China, Zhejiang|
|$295K||10 Mar 2017||Barcelona, Catalonia, Spain|
|$141K||01 Dec 2016||Barcelona, Catalonia, Spain|
|$280K||01 Aug 2011||Chicago, Illinois, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.